*ST海航(600221.SH):部分董監高擬合計增持285萬股-565萬股
格隆匯2月14日丨*ST海航(600221.SH)公佈,公司董事長陳明,董事兼總裁徐軍,董事兼副總裁伍曉熹、劉強,監事會主席楊新瑩,監事蕭飛、郭贇、趙國剛、曹京斐,副總裁高建,財務總監張鴻清,副總裁兼董事會祕書李曉峯,安全總監王新震,計劃於2022年2月15日起6個月內通過上海證券交易所集中競價交易系統增持公司股份。本次擬增持數量合計為285萬股至565萬股(約佔公司總股本的0.009%至0.017%)。本次增持不設價格區間,將根據公司股票價格波動情況及資本市場整體趨勢實施增持。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.